Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Sangamo Therapeutics GAAP EPS of $0.04 Beats by $0.08, Revenue of $49.41M Beats by $24.34M
ARKK's Holdings Ranked by SA Quant Grades
Chevron, Super Micro Computer Top List of Most Shorted Large-cap Stocks in October, Hazeltree Says
Zeta Global, Spirit Airlines And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
CRISPR, Beam, Other Gene Editing Names up Significantly
9 Analysts Have This To Say About Intellia Therapeutics